Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs DECIPHER LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CORAL LAB. DECIPHER LABS CORAL LAB./
DECIPHER LABS
 
P/E (TTM) x 14.6 -2.1 - View Chart
P/BV x 0.9 0.6 133.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 CORAL LAB.   DECIPHER LABS
EQUITY SHARE DATA
    CORAL LAB.
Mar-23
DECIPHER LABS
Mar-23
CORAL LAB./
DECIPHER LABS
5-Yr Chart
Click to enlarge
High Rs36863 584.1%   
Low Rs21714 1,544.5%   
Sales per share (Unadj.) Rs218.845.1 485.0%  
Earnings per share (Unadj.) Rs18.1-2.7 -679.9%  
Cash flow per share (Unadj.) Rs24.2-2.2 -1,082.2%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs433.623.0 1,887.0%  
Shares outstanding (eoy) m3.5710.10 35.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.30.9 156.7%   
Avg P/E ratio x16.2-14.5 -111.8%  
P/CF ratio (eoy) x12.1-17.3 -70.2%  
Price / Book Value ratio x0.71.7 40.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,045389 268.6%   
No. of employees `000NANA-   
Total wages/salary Rs m111412 27.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m781456 171.4%  
Other income Rs m6974 93.5%   
Total revenues Rs m850529 160.6%   
Gross profit Rs m39-106 -36.2%  
Depreciation Rs m224 509.3%   
Interest Rs m35 70.3%   
Profit before tax Rs m82-42 -197.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m18-15 -120.6%   
Profit after tax Rs m64-27 -240.3%  
Gross profit margin %4.9-23.3 -21.1%  
Effective tax rate %21.635.5 61.0%   
Net profit margin %8.3-5.9 -140.2%  
BALANCE SHEET DATA
Current assets Rs m1,235201 615.1%   
Current liabilities Rs m11950 239.3%   
Net working cap to sales %143.033.2 430.7%  
Current ratio x10.44.1 257.1%  
Inventory Days Days23130 766.8%  
Debtors Days Days1,094789 138.7%  
Net fixed assets Rs m50871 718.2%   
Share capital Rs m36101 35.4%   
"Free" reserves Rs m1,512131 1,153.6%   
Net worth Rs m1,548232 667.0%   
Long term debt Rs m00-   
Total assets Rs m1,743272 642.0%  
Interest coverage x25.3-7.6 -331.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.41.7 26.7%   
Return on assets %3.9-8.1 -48.0%  
Return on equity %4.2-11.6 -36.0%  
Return on capital %5.5-15.8 -34.9%  
Exports to sales %92.10-   
Imports to sales %00-   
Exports (fob) Rs m719NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m7190-   
Fx outflow Rs m130-   
Net fx Rs m7060-   
CASH FLOW
From Operations Rs m127-16 -809.3%  
From Investments Rs m-26-43 61.2%  
From Financial Activity Rs m-64-22 298.9%  
Net Cashflow Rs m36-80 -45.4%  

Share Holding

Indian Promoters % 20.0 0.0 -  
Foreign collaborators % 51.5 16.4 313.7%  
Indian inst/Mut Fund % 0.1 0.0 -  
FIIs % 0.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 28.5 83.6 34.1%  
Shareholders   4,005 34,511 11.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CORAL LAB. With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on CORAL LAB. vs COMBAT DRUGS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

CORAL LAB. vs COMBAT DRUGS Share Price Performance

Period CORAL LAB. COMBAT DRUGS S&P BSE HEALTHCARE
1-Day -3.68% 0.68% 1.18%
1-Month 2.65% -17.62% -0.75%
1-Year 65.07% -1.07% 61.82%
3-Year CAGR 4.80% -24.12% 18.16%
5-Year CAGR 3.18% -10.83% 19.79%

* Compound Annual Growth Rate

Here are more details on the CORAL LAB. share price and the COMBAT DRUGS share price.

Moving on to shareholding structures...

The promoters of CORAL LAB. hold a 71.5% stake in the company. In case of COMBAT DRUGS the stake stands at 16.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of CORAL LAB. and the shareholding pattern of COMBAT DRUGS.

Finally, a word on dividends...

In the most recent financial year, CORAL LAB. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

COMBAT DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of CORAL LAB., and the dividend history of COMBAT DRUGS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.